UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 15, 2016

                                 AMERICANN, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)


           Delaware                    000-54231                27-4336843
  ------------------------          -----------------         ----------------
(State or other jurisdiction      (Commission File No.)     (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                  -------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000


          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01.  Entry Into a Material Definitive Agreement

Massachusetts Medical Cannabis Center

     Previously  the Company  entered  into an agreement to purchase a 52.6-acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to December 29,  2015.  These  payments of $300,000  will be applied to the
purchase price.

     On August 15, 2016 the Company and seller  amended the  Agreement to extend
the closing date to September  15, 2016. As  consideration  for the extension of
the closing  date,  the Company  agreed to increase the  purchase  price for the
property to $4,400,000  and pay the seller  $75,000 which will be applied to the
purchase price if the closing occurs.

     By September 15, 2016, the Company, at its election, may extend the closing
date to October 15, 2016, in which case the purchase price for the property will
be  $4,475,000  and the Company  will pay an  additional  $75,000 to the seller,
which payment will be applied to the purchase price if the closing occurs.

     To date, the Company has paid $850,000 that will be applied to the purchase
price of the property if and when the Company closes on the transaction.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under
           an Off-Balance Sheet Arrangement of a Registrant.

     On August 15, 2016 the Company  borrowed  $100,000 from an unrelated  third
party. The loan bears interest at 12% per year and matures on December 14, 2016.
Interest is payable at maturity.  The loan is not convertible into shares of the
Company's common stock and is unsecured.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: August 18, 2016
                                      AMERICANN, INC.


                                      By: /s/ Timothy Keogh
                                          ------------------------------
                                          Timothy Keogh, Chief Executive
                                          Officer








                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101freetownex8-16.txt", "description": "8-K RE FREETOWN EXTENDED CLOSING", "secsgml_size_bytes": 5393}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "161844766"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (date of earliest event reported): August 15, 2016

                                 AMERICANN, INC.
                       -----------------------------------
             (Exact name of registrant as specified in its charter)

           Delaware                    000-54231                27-4336843
  ------------------------          -----------------         ----------------
(State or other jurisdiction      (Commission File No.)     (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                  -------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

Massachusetts Medical Cannabis Center

     Previously  the Company  entered  into an agreement to purchase a 52.6-acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to December 29,  2015.  These  payments of $300,000  will be applied to the
purchase price.

     On August 15, 2016 the Company and seller  amended the  Agreement to extend
the closing date to September  15, 2016. As  consideration  for the extension of
the closing  date,  the Company  agreed to increase the  purchase  price for the
property to $4,400,000  and pay the seller  $75,000 which will be applied to the
purchase price if the closing occurs.

     By September 15, 2016, the Company, at its election, may extend the closing
date to October 15, 2016, in which case the purchase price for the property will
be  $4,475,000  and the Company  will pay an  additional  $75,000 to the seller,
which payment will be applied to the purchase price if the closing occurs.

     To date, the Company has paid $850,000 that will be applied to the purchase
price of the property if and when the Company closes on the transaction.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under
           an Off-Balance Sheet Arrangement of a Registrant.

     On August 15, 2016 the Company  borrowed  $100,000 from an unrelated  third
party. The loan bears interest at 12% per year and matures on December 14, 2016.
Interest is payable at maturity.  The loan is not convertible into shares of the
Company's common stock and is unsecured.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: August 18, 2016
                                      AMERICANN, INC.

                                      By: /s/ Timothy Keogh
                                          ------------------------------
                                          Timothy Keogh, Chief Executive
                                          Officer

                                       3